Director Alan Mateo's Form 4 Filing for 10x Genomics Restricted Stock Units

This Form 4 filing reports that Alan Mateo, a director of 10x Genomics, Inc., received 8,829 restricted stock units (RSUs) on June 4, 2026. The RSUs represent a contingent right to receive shares of Class A Common Stock upon vesting, with 1/4 of the units vesting on each quarterly anniversary starting from May 21, 2026, subject to continued service. The transaction was reported at $0.00 per share, as is typical for RSU grants. Following this award, Mateo holds 85,877 shares of Class A Common Stock. The filing includes a Power of Attorney document executed on March 5, 2026, authorizing Randy Wu and James Bryant to file Section 16 reports on Mateo's behalf. This represents standard equity compensation for a company director.